stars 1 stars 2 stars 3

We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at and connect on Twitter and Facebook @Sunovion. LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd. APTIOM is used under license from BIAL. KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc. © 2023 Sunovion Pharmaceuticals Inc. To view our community guidelines, see here:

View Top Employees from Sunovion Pharmaceuticals
Revenue $546 million
Employees 2,095 (2,095 on RocketReach)
Founded 2010
Address 84 Waterford Dr, Marlborough, Massachusetts 01752, US
Phone (508) 481-6700
Category Pharmaceutical Manufacturing, Pharmaceuticals, Central Nervous System, Healthcare, Respiratory
Web Rank 2 Million
Keywords sep-363856, apomorphine fda, dasotraline,, google map for sunovion in marribor ma
Competitors Acadia Pharmaceuticals Inc., Alkermes, Amarin Corporation, Avanir Pharmaceuticals, Luye Pharma Group
SIC 28, 283
NAICS 32, 62151, 621, 62, 325, 6215, 32541, 3254

Sunovion Pharmaceuticals Questions

The Sunovion Pharmaceuticals annual revenue was $546 million in 2023.

Armin Szegedi is the Senior Vice President and Chief Medical Officer of Sunovion Pharmaceuticals.

2,095 people are employed at Sunovion Pharmaceuticals.

Sunovion Pharmaceuticals is based in Marlborough, Massachusetts.

The NAICS codes for Sunovion Pharmaceuticals are [32, 62151, 621, 62, 325, 6215, 32541, 3254].

The SIC codes for Sunovion Pharmaceuticals are [28, 283].

Top Sunovion Pharmaceuticals Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users